Related Blog Posts
Drug research updates-
18 hours ago ago from Pharmacy Education And Research .Com
Celebrex may interfere with cardioprotective benefit of aspirin. The pain killer celecoxib (Celebrex) may interfere with the cardioprotective benefit of low-dose aspirin, researchers found." The researchers reported online in the Proceedings of the National Academy of Sciences that celecoxib "tightly binds to one form of Cox-1 that prevents aspirin from reaching its antiplatelet target." In addition, the researchers "confirmed that ...
Related contentANOTHER NHS NIGHTMARE: WON'T PAY FOR MOTHER'S CANCER DRUGS
7 hours ago ago from THE ASTUTE BLOGGERS
THE SENTINEL (UK): CANCER sufferer Viv Foster has lost her appeal to have Herceptin on the NHS. The snub leaves 52-year-old Viv needing to find at least £16,000 more to pay for the drug. The mother-of-two, pictured right, has already spent £10,000 on three-weekly doses of Herceptin since first being told by NHS Stoke-on-Trent that she could not have the drug. Trust officials ruled her cancer was not big enough to justify a ...
Related contentBreast Cancer And Chemotherapy – LR
4 hours ago ago from Cancer News, Treatment, Prevention
Breast chemotherapy refers to the treatment applied to patients who suffer from breast cancer. Its purpose is to kill or to reduce in size the tumor consisting of cells that multiply very quickly compared to the normal rate of multiplication of normal cells. Breast chemotherapy can be of very many kinds depending on the combination of drugs that the doctor has selected for you. Correct information on the way the medication works as well as an ...
Related contentTroubleshooters that block cancer
5 hours ago ago from Health News
Scientists have shown how a family of proteins play a crucial role in repairing the DNA damage which can lead to cancer. They hope the finding could pave the way for a new type of drug which could help kill cancer cells, and promote production of healthy replacements. The proteins seem to have a remarkable ability to zero in on damaged areas. The breakthrough, uncovered independently by two teams, appears in the journal Nature. ...
Related contentAntibody-guided drug shows encouraging activity in metastatic breast cancer
6 hours ago ago from Medical news and articles
A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data. View post: Antibody-guided drug shows encouraging activity in metastatic breast cancer
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
